Development and immunobiological evaluation of nanoparticles containing an immunodominant epitope of herpes simplex virus
Abstract Herpes simplex virus (HSV) 1 and 2 are viruses that infect individuals worldwide and for which there is no cure or vaccine available. The protective response against herpes is mostly mediated by CD8 T lymphocytes that respond to the immunodominant SSIEFARL epitope. However, there are some o...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-08-01
|
| Series: | IET Nanobiotechnology |
| Online Access: | https://doi.org/10.1049/nbt2.12043 |